Oral Clomiphene vs. Injectable Gonadotropins in Ovulation Induction: A Comparative Study of Efficacy and Outcomes
Annals of International Medical and Dental Research · 2026-08 · 12 (4) · 50-55
DOI: 10.53339/aimdr.2026.12.4.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of International Medical and Dental Research, 2026-08. Verfasst von Hema Sanjeed und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Infertility affects a significant proportion of couples worldwide, with anovulatory disorders being a leading cause among women. Ovulation induction remains a cornerstone of treatment, with oral clomiphene citrate commonly used as a first-line agent due to its simplicity, cost-effectiveness, and favorable safety profile. Injectable gonadotropins, including FSH and hMG, are reserved for patients who do not respond to clomiphene or require higher efficacy. This study aimed to compare oral clomiphene citrate and injectable gonadotropins for ovulation induction.
Methods
This prospective comparative study was conducted at 250 Bed General Hospital, Noakhali, Bangladesh, from January to December 2025, including 68 infertile women aged 20–35 years with anovulatory cycles or PCOS. Participants were equally divided into two groups: Group A received oral clomiphene citrate (50–100 mg/day for 5 days) starting on day 2–5 of the menstrual cycle, and Group B received injectable gonadotropins (FSH or hMG) with individualized dosing. Data were analyzed using SPSS v. 25.
Result
Among 68 women, baseline characteristics were similar between groups. Gonadotropins achieved higher ovulation (85.3% vs. 67.6%, P = 0.04), more mature follicles (2.3 ± 0.9 vs. 1.4 ± 0.6, P < 0.001), and thicker endometrium (9.1 ± 1.4 mm vs. 7.6 ± 1.2 mm, P < 0.001) than clomiphene. Pregnancy rates were higher with gonadotropins (clinical 35.3% vs. 20.6%), though not statistically significant. Gonadotropin cycles required longer stimulation and more monitoring, with increased complications including multiple follicles, OHSS, and multiple pregnancies (32.4% vs. 11.8%). Overall, gonadotropins were more effective but had a greater treatment burden and risk.
Conclusion
Injectable gonadotropins showed superior ovulation and pregnancy outcomes compared to oral clomiphene citrate, with enhanced follicular development and thicker endometrium. However, this increased efficacy came with more complex treatment, additional monitoring, and a higher risk of complications.
Zitieren
APA
Sanjeed, H., Begum, S., & Hossain, M. S. (2026). Oral Clomiphene vs. Injectable Gonadotropins in Ovulation Induction: A Comparative Study of Efficacy and Outcomes. Annals of International Medical and Dental Research, 12(4), 50-55. https://doi.org/10.53339/aimdr.2026.12.4.8
Vancouver
Sanjeed H, Begum S, Hossain MS. Oral Clomiphene vs. Injectable Gonadotropins in Ovulation Induction: A Comparative Study of Efficacy and Outcomes. Annals of International Medical and Dental Research. 2026;12(4):50-55. doi:10.53339/aimdr.2026.12.4.8
BibTeX
@article{Sanjeed2026,
author = {Sanjeed, Hema and Begum, Shahana and Hossain, Mohammad Saljar},
title = {Oral Clomiphene vs. Injectable Gonadotropins in Ovulation Induction: A Comparative Study of Efficacy and Outcomes},
journal = {Annals of International Medical and Dental Research},
year = {2026},
volume = {12},
number = {4},
pages = {50--55},
doi = {10.53339/aimdr.2026.12.4.8}
}
EUVIMED